CDKL2抗体,Rabbit Polyclonal CDKL2 Antibody
  • CDKL2抗体,Rabbit Polyclonal CDKL2 Antibody
  • CDKL2抗体,Rabbit Polyclonal CDKL2 Antibody
  • CDKL2抗体,Rabbit Polyclonal CDKL2 Antibody

CDKL2抗体;CDKL2 Antibody—艾普蒂

价格 询价
包装 20μl 50μl 100μl
最小起订量 1μl
发货地 上海
更新日期 2025-05-28
QQ交谈 微信洽谈

产品详情

中文名称:CDKL2抗体英文名称:Rabbit Polyclonal CDKL2 Antibody
品牌: 艾普蒂产地: 武汉
保存条件: Stored at -20°C for 7025 year. Avoid repeated freeze / thaw cycles.产品类别: 抗体
重组: 应用: WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性: Human,Mouse,Rat 宿主: Rabbit
偶联物: 靶点: CDKL2
2025-05-28 CDKL2抗体 Rabbit Polyclonal CDKL2 Antibody 20μl/RMB;50μl/RMB;100μl/RMB 艾普蒂 武汉 Stored at -20°C for 7025 year. Avoid repeated freeze / thaw cycles. 抗体

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/25-1/100 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesP56; KKIAMRE
WB Predicted band size56 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenSynthetic peptide of human CDKL2
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Mouse brain tissue lysate, Primary antibody: P13051(CDKL2 Antibody) at dilution 1/250, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 30 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P13051(CDKL2 Antibody) at dilution 1/25. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human lung cancer tissue using P13051(CDKL2 Antibody) at dilution 1/25. (Original magnification: ×200)    


           

参考文献

以下是关于CDKL2抗体的虚构参考文献示例(注:实际文献需通过学术数据库检索,以下内容仅供格式参考):

---

1. **文献名称**: *CDKL2 Kinase Expression in Non-Small Cell Lung Cancer: A Prognostic Marker Study*

**作者**: Smith A, et al.

**摘要**: 本研究通过免疫组化(IHC)和Western blot技术,利用CDKL2特异性抗体分析了CDKL2在非小细胞肺癌组织中的表达。结果显示,CDKL2高表达与患者不良预后相关,提示其可能作为肺癌治疗的潜在靶点。

---

2. **文献名称**: *Characterization of CDKL2 Antibody for Neuronal Subcellular Localization*

**作者**: Lee J, et al.

**摘要**: 文章报道了一种新型CDKL2多克隆抗体的开发与验证,通过免疫荧光和共聚焦显微镜技术证实CDKL2主要定位于神经元胞体及树突,并参与突触可塑性调控。

---

3. **文献名称**: *CDKL2 in Cell Cycle Regulation: Insights from Knockdown and Antibody-Based Assays*

**作者**: Garcia R, et al.

**摘要**: 利用CDKL2抗体进行流式细胞术和免疫沉淀实验,研究发现CDKL2通过与Cyclin B1相互作用调控G2/M期转换,其表达缺失导致细胞周期停滞。

---

4. **文献名称**: *Epigenetic Silencing of CDKL2 in Breast Cancer via Antibody-Mediated Detection*

**作者**: Chen H, et al.

**摘要**: 通过CDKL2抗体检测乳腺癌组织中蛋白表达,结合甲基化分析,发现CDKL2启动子高甲基化导致其表达下调,且与肿瘤侵袭性增强相关。

---

**建议**:实际研究中,建议通过PubMed或Google Scholar以关键词“CDKL2 antibody”或“CDKL2 kinase function”检索最新文献,重点关注抗体应用(如IHC、WB)及疾病机制研究。

       

背景信息

The CDKL2 (Cyclin-Dependent Kinase-Like 2) antibody is a tool used to study the CDKL2 protein, a member of the CDKL family, which shares structural similarities with CDKL5. CDKL2 is a serine/threonine kinase implicated in regulating cellular processes such as cell cycle progression, signal transduction, and neuronal development. Though less studied than CDKL5. CDKL2 is believed to interact with substrates involved in microtubule dynamics and synaptic plasticity. Its expression is observed in various tissues, including the brain, with potential roles in neurodevelopment and cancer. Dysregulation of CDKL2 has been loosely associated with cancers (e.g., breast, lung) and neurological disorders, though direct mechanistic links remain under investigation.

CDKL2 antibodies are primarily used in research to detect protein expression, localization, and post-translational modifications via techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF). These antibodies help elucidate CDKL2's functional pathways and its interplay with other kinases or disease-related proteins. Commercial CDKL2 antibodies are typically raised in hosts like rabbits or mice, with both polyclonal and monoclonal options available. Validation often involves knockout cell lines or siRNA-mediated silencing to confirm specificity. Researchers emphasize the need for rigorous validation due to cross-reactivity risks with homologous kinases like CDKL1 or CDKL5. As interest grows in CDKL family proteins as therapeutic targets, CDKL2 antibodies remain critical for advancing understanding of its biological and pathological significance.

       
关键字: CDKL2抗体;CDKL2;CDKL2 Antibody;

公司简介

生物技术有限公司
成立日期 2024-07-02 (2年) 注册资本 20万人民币
员工人数 1-10人 年营业额 ¥ 100万以内
主营行业 抗体,植物生物技术,细胞培养,蛋白组学 经营模式 贸易,工厂,试剂,定制,服务
  • 上海切尔齐生物科技有限公司
VIP 1年
  • 公司成立:2年
  • 注册资本:20万人民币
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:生物试剂
  • 公司地址:青浦
询盘

CDKL2抗体;CDKL2 Antibody—艾普蒂相关厂家报价

产品名称 价格   公司名称 报价日期
询价
VIP3年
维百奥(北京)生物科技有限公司
2025-10-27
¥1800
VIP1年
费雪(杭州)医学研究有限公司
2025-11-03
询价
上海华盈生物医药科技有限公司
2025-11-09
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.